Symbicort vs Ventolin
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| CA Symbicort | CA Ventolin | |
|---|---|---|
| Generic name | budesonide/formoterol | salbutamol |
| Drug class | Inhaled Corticosteroid + LABA | Short-Acting Beta-2 Agonist (SABA) |
| Treats | Asthma, COPD | Asthma, bronchospasm |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | GSK |
| Year approved | 2002 | 1981 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $11M | $6M |
| Common side effects | Thrush, Headache, Respiratory infections, Tremor | Tremor, Fast heartbeat, Nervousness, Headache |
Symbicort
Frequently asked questions
Is Symbicort or Ventolin better?
Neither is universally "better." Symbicort (budesonide/formoterol) and Ventolin (salbutamol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Symbicort and Ventolin?
Symbicort is a Inhaled Corticosteroid + LABA made by AstraZeneca, while Ventolin is a Short-Acting Beta-2 Agonist (SABA) made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Symbicort has the larger estimated TV advertising budget of the two.